NDC 0002-5337

Verzenio

Abemaciclib

Verzenio is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Abemaciclib.

• Product ID: 0002-5337_268939ac-da7c-4fb5-ba8d-0d59aed8df3f
• NDC: 0002-5337
• Product Type: Human Prescription Drug
• Proprietary Name: Verzenio
• Generic Name: Abemaciclib
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2017-09-28
• Marketing Category: NDA / NDA
• Application Number: NDA208716
• Labeler Name: Eli Lilly and Company
• Substance Name: ABEMACICLIB
• Active Ingredient Strength: 150 mg/1
• Pharm Classes: Kinase Inhibitors [MoA],Kinase Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0002-5337-54

1 BLISTER PACK in 1 CARTON (0002-5337-54) > 14 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2017-10-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-5337-63 [00002533763]

Verzenio TABLET

• Marketing Category: NDA
• Application Number: NDA208716
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-03-05

NDC 0002-5337-54 [00002533754]

Verzenio TABLET

• Marketing Category: NDA
• Application Number: NDA208716
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-10-06

Drug Details

Active Ingredients

Ingredient	Strength
ABEMACICLIB	150 mg/1

OpenFDA Data

• SPL SET ID: be4bc0de-0fdc-4d46-8d25-be43c79e6a06
• Manufacturer:
  • Eli Lilly and Company
• UNII:
  • 60UAB198HK
• RxNorm Concept Unique ID - RxCUI:
  • 1946848
  • 1946838
  • 1946836
  • 1946842
  • 1946840
  • 1946846
  • 1946830
  • 1946844

Pharmacological Class

• Kinase Inhibitors [MoA]
• Kinase Inhibitor [EPC]

NDC Crossover Matching brand name "Verzenio" or generic name "Abemaciclib"

NDC	Brand Name	Generic Name
0002-4483	Verzenio	abemaciclib
0002-4815	Verzenio	abemaciclib
0002-5337	Verzenio	abemaciclib
0002-6216	Verzenio	abemaciclib